Authors,Author(s) ID,Title,Year,Source tittle,Cited by,DOI,Country,Document Type,City,Access Type,aggregationType,EID
Gonzalez-Suarez E.,,RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis,2010,Nature,363,10.1038/nature09495,Spain;United States,Article,Hospitalet de Llobregat;Seattle,0,Journal,2-s2.0-78149284767
Schramek D.,,Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer,2010,Nature,389,10.1038/nature09387,Austria,Article,Vienna,0,Journal,2-s2.0-78149284013
Grivennikov S.,,"Immunity, Inflammation, and Cancer",2010,Cell,5504,10.1016/j.cell.2010.01.025,United States,Review,San Diego,1,Journal,2-s2.0-77950346282
Body J.J.,,Effects of denosumab in patients with bone metastases with and without previous bisphosphonate exposure,2010,Journal of Bone and Mineral Research,100,10.1359/jbmr.090810,Belgium,Article,Brussels,0,Journal,2-s2.0-77953438942
Liao D.,,Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model,2009,PLoS ONE,278,10.1371/journal.pone.0007965,United States,Article,San Diego,1,Journal,2-s2.0-70949103794
DeNardo D.G.,,CD4<sup>+</sup> T Cells Regulate Pulmonary Metastasis of Mammary Carcinomas by Enhancing Protumor Properties of Macrophages,2009,Cancer Cell,783,10.1016/j.ccr.2009.06.018,United States,Article,San Francisco,1,Journal,2-s2.0-67651160649
Fizazi K.,,"Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates",2009,Journal of Clinical Oncology,428,10.1200/JCO.2008.19.2146,France,Article,Saint-Aubin,0,Journal,2-s2.0-63749094012
Ohara M.,,Possible involvement of regulatory T cells in tumor onset and progression in primary breast cancer,2009,"Cancer Immunology, Immunotherapy",64,10.1007/s00262-008-0570-x,Japan,Article,Higashihiroshima,1,Journal,2-s2.0-58149305541
Gobert M.,,Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical utcome,2009,Cancer Research,404,10.1158/0008-5472.CAN-08-2360,France;France;France;France,Article,Villeurbanne;Lyon;Lyon;Lyon,1,Journal,2-s2.0-62449250053
Bohling S.,,Immunosuppressive regulatory T cells are associated with aggressive breast cancer phenotypes: A potential therapeutic target,2008,Modern Pathology,99,10.1038/modpathol.2008.160,United States,Article,Seattle,1,Journal,2-s2.0-56649102194
Karnoub A.E.,,Mesenchymal stem cells within tumour stroma promote breast cancer metastasis,2007,Nature,2170,10.1038/nature06188,United States,Article,Cambridge,0,Journal,2-s2.0-34948896045
Cao Y.,,IκB kinase α kinase activity is required for self-renewal of ErbB2/Her2-transformed mammary tumor-initiating cells,2007,Proceedings of the National Academy of Sciences of the United States of America,118,10.1073/pnas.0706728104,United States,Article,San Diego,1,Journal,2-s2.0-35648970074
Luo J.L.,,Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin,2007,Nature,334,10.1038/nature05656,United States,Article,San Diego,0,Journal,2-s2.0-34247274248
Bates G.J.,,Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse,2006,Journal of Clinical Oncology,719,10.1200/JCO.2006.05.9584,United Kingdom,Article,Oxford,0,Journal,2-s2.0-34247261531
Jones D.H.,,Regulation of cancer cell migration and bone metastasis by RANKL,2006,Nature,553,10.1038/nature04524,Canada;Austria;Canada,Article,Toronto;Vienna;Oshawa,1,Journal,2-s2.0-33645453481
Kawai T.,,B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease,2006,American Journal of Pathology,320,10.2353/ajpath.2006.060180,United States,Article,Boston,0,Journal,2-s2.0-33748788554
Ercolini A.M.,,Recruitment of latent pools of high-avidity CD8<sup>+</sup> T cells to the antitumor immune response,2005,Journal of Experimental Medicine,350,10.1084/jem.20042167,United States;United States,Article,Baltimore;Baltimore,1,Journal,2-s2.0-21144454780
Fontenot J.,,Foxp3 programs the development and function of CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cells,2003,Nature Immunology,5412,10.1038/ni904,United States,Article,Seattle,0,Journal,2-s2.0-0037385330
Cao Y.,,IKKα provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development,2001,Cell,370,10.1016/S0092-8674(01)00599-2,United States,Article,San Diego,1,Journal,2-s2.0-0035861314
Fata J.,,The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development,2000,Cell,547,10.1016/S0092-8674(00)00103-3,Canada;United States,Article,Toronto;Thousand Oaks,1,Journal,2-s2.0-0034730327
Luboshits G.,,"Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma",1999,Cancer Research,245,,Israel,Article,Tel Aviv-Yafo,0,Journal,2-s2.0-0033568215
Dougall W.,,RANK is essential for osteoclast and lymph node development,1999,Genes and Development,1058,10.1101/gad.13.18.2412,United States,Article,Kirtland,1,Journal,2-s2.0-0033568341
Hsu H.,,Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand,1999,Proceedings of the National Academy of Sciences of the United States of America,1332,10.1073/pnas.96.7.3540,United States,Article,Thousand Oaks,1,Journal,2-s2.0-13044316551
Gao J.,,Structure and functional expression of the human macrophage inflammatory protein lc/RANTES Receptor,1993,Journal of Experimental Medicine,334,10.1084/jem.177.5.1421,United States,Article,Bethesda,1,Journal,2-s2.0-0027479459
Guy C.T.,,Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease,1992,Proceedings of the National Academy of Sciences of the United States of America,896,10.1073/pnas.89.22.10578,Canada,Article,Hamilton,1,Journal,2-s2.0-0026472124
Tiwari R.K.,,HER-2/neu amplification and overexpression in primary human breast cancer is associated with early metastasis,1992,Anticancer Research,99,,United States,Article,New York,0,Journal,2-s2.0-0026582760
Slamon D.J.,,Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer,1989,Science,5852,10.1126/science.2470152,United States,Article,Los Angeles,0,Journal,2-s2.0-0024337144
